14-Mar-2025
Mizuho Securities Reaffirms Their Hold Rating on LifeMD (LFMD)
TipRanks (Thu, 13-Mar 2:31 AM ET)
TipRanks (Wed, 12-Mar 6:27 AM ET)
LifeMD, Inc. Reports Strong Telehealth Growth Amid Challenges
TipRanks (Tue, 11-Mar 8:19 PM ET)
TipRanks (Tue, 11-Mar 9:20 AM ET)
Lake Street Keeps Their Buy Rating on LifeMD (LFMD)
TipRanks (Tue, 11-Mar 9:18 AM ET)
Benzinga (Tue, 11-Mar 6:52 AM ET)
TipRanks (Tue, 11-Mar 3:40 AM ET)
LifeMD beats top-line and bottom-line estimates; initiates Q1 and FY25 outlook
Seeking Alpha News (Tue, 11-Mar 12:52 AM ET)
LifeMD, Inc. Reports Strong Q4 2024 Results
TipRanks (Tue, 11-Mar 12:00 AM ET)
LifeMD Reports Fourth Quarter 2024 Results
Globe Newswire (Mon, 10-Mar 5:30 PM ET)
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.
Lifemd trades on the NASDAQ stock market under the symbol LFMD.
As of March 14, 2025, LFMD stock price climbed to $5.94 with 1,482,810 million shares trading.
LFMD has a market cap of $264.83 million. This is considered a Small Cap stock.
Last quarter Lifemd reported $64 million in Revenue and $.21 earnings per share. This beat revenue expectation by $7 million and exceeded earnings estimates by $.26.
In the last 3 years, LFMD traded as high as $12.88 and as low as $1.14.
The top ETF exchange traded funds that LFMD belongs to (by Net Assets): IWM, VTI, VXF, IWO, VTWO.
LFMD has underperformed the market in the last year with a return of -39.2%, while SPY returned +11.0%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in LFMD shares. However, LFMD has outperformed the market in the last 3 month and 2 week periods, returning +4.4% and +12.9%, while SPY returned -6.5% and -5.3%, respectively. This indicates LFMD has been having a stronger performance recently.
LFMD support price is $5.25 and resistance is $6.07 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LFMD shares will trade within this expected range on the day.